Shandong Boan Biotechnology (06955) released its monthly return for the period ended 31 October 2025, showing no modifications to its registered share capital. The total registered capital remained at RMB 622,333,694, divided into 622,333,694 ordinary H shares at RMB 1 each.
The issuer reported no changes in issued shares and treasury shares. The number of issued H shares stayed at 622,333,694, and no adjustments were made through share options, warrants, convertibles, or any other share issuance arrangements. The announcement was submitted by Director Jiang Hua on 5 November 2025.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments